FDAFDA · Food and drugs·Recall number D-0838-2020
Pioglitazone and Metformin Hydrochloride Tablets, USP 15 mg/500 mg, Rx Only, 60-count bottle, Manufactured for Macleods Pharma USA, Inc. Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, India, NDA 33342-176-09
Published February 12, 2020 · Recall initiated: January 24, 2020
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent Drug: Out of specification assay result, below specification, for two lots of Pioglitazone And Metformin Hydrochloride Tablets.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- PIOGLITAZONE AND METFORMIN HYDROCHLORIDE
- Manufacturer
- Macleods Pharma Usa Inc
- Distributor
- Nationwide
- UPC
- 0333342177117
- Lot
- Lot# BPA5903A, EXP 05/2021; BPA5819A, EXP 11/2020
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.